Somatic Overgrowth and Vascular Anomalies


Working Group Charter

Work Product Title

Best Practices in Diagnostic Testing for Disorders of Somatic Overgrowth and Vascular Anomalies 

Work Product Category

Manuscript or Publication: Practice guideline/Review of genetic/genomic abnormalities and their clinical significance

Specific Aims for the Work Product

  • Propose Best Practices and Guidelines for Genetic Testing and Clinical Management of individuals with Vascular Anomalies and/or Overgrowth Disorders

  • Guidelines for classification of somatic variants in genes associated with Vascular Anomalies and/or Overgrowth Disorders

Overview

Vascular anomalies and overgrowth disorders are typically caused by variants that occur in only a subset of cells, attributed to mosaicism. Due to the mosaic occurrence of these variants, they are poorly detected in blood, necessitating sensitive assays to detect them in affected tissues. We will perform a comprehensive literature review of current testing practices, compare testing practices in four academic medical centers (University of Washington in St. Louis, Seattle Children’s Hospital, Nationwide Children’s Hospital, and Children’s Hospital Los Angeles) and propose evidence-based guidelines for optimal diagnosis of vascular anomalies and overgrowth disorders. Additionally, we will review recurrent and major classes of genomic aberrations in the different types of vascular malformations.

Current ACMG/AMP variant classification guidelines focus on germline conditions, and AMP/ASCO/CAP guidelines focus on variant classification in cancer. While specific guidelines for somatic variants in the genes AKT3, MTOR, PIK3CA, and PIK3R2 associated with brain malformations have recently been published by ClinGen, general guidelines for somatic variants in vascular and overgrowth disorders are lacking and will be addressed in this aim.


Working Group Members

Working Group LeadersYang Cao

Yang Cao 
Washington University in St. Louis


Avinash Dharmadhikari

Avinash V. Dharmadhikari 
Children’s Hospital Los Angeles

Working Group Members

Denise Adams
Children's Hospital of Philadelphia

Catherine Cottrell
Nationwide Children's Hospital

Adrienne Hammill
Cincinnati Children’s Hospitalof Texas MD Anderson Cancer Center

Patricia Hernandez
Washington University in St. Louis

Claire Hou
Nationwide Children's Hospital

Katherine King
Washington University

Jie Liu
Cincinnati Children's Hospital

Bahareh Majored
BC  Cancer

Candace Myers
Seattle Children’s Hospital

Thuy Phung
University of South Alabama

Lea F. Surry
Children's Hospital of Philadelphia

CGC Board Liaison

Cate Paschal
Seattle Children’s Hospital

               

Working Groups Home